Wright State University

CORE Scholar
Browse all Theses and Dissertations

Theses and Dissertations

2009

The Presynaptic Regulation of Isolated Neonatal Rat Carotid Body
Type I Cells by Histamine
Drew C. Burlon
Wright State University

Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all
Part of the Anatomy Commons

Repository Citation
Burlon, Drew C., "The Presynaptic Regulation of Isolated Neonatal Rat Carotid Body Type I Cells by
Histamine" (2009). Browse all Theses and Dissertations. 304.
https://corescholar.libraries.wright.edu/etd_all/304

This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has
been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE
Scholar. For more information, please contact library-corescholar@wright.edu.

THE PRESYNAPTIC REGULATION OF ISOLATED
NEONATAL RAT CAROTID BODY
TYPE I CELLS BY HISTAMINE.

A thesis submitted in partial fulfillment
of the requirements for the degree of
Master of Science

By

DREW C. BURLON
B.S., University of Dayton, 2006

2009
Wright State University

WRIGHT STATE UNIVERSITY
SCHOOL OF GRADUATE STUDIES

August 11th, 2009
I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY
SUPERVISION BY Drew Burlon ENTITLED The Presynaptic Regulation of Neonatal
Rat Carotid Body Type I Cells by Histamine BE ACCEPTED IN PARTIAL
FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of
Science.

___________________________
Christopher N. Wyatt, Ph.D.
Thesis Director

___________________________
Timothy C. Cope, Ph.D.
Department Chair
Signatures of Committee
on Final Examination

______________________________
Christopher N. Wyatt, Ph.D.
______________________________
Robert W. Putnam, Ph.D.
______________________________
Kathrin L. Engisch , Ph.D.
______________________________
Joseph F. Thomas, Ph.D.
Dean, School of Graduate Studies

ABSTRACT

Burlon, Drew C. M.S., Department of Neuroscience, Cell Biology and Physiology,
Wright State University, 2009. The Presynaptic Regulation of Isolated Neonatal Rat
Carotid Body Type I Cells by Histamine.

It has been previously shown that Carotid Body Type I cells have the ability to
synthesize, package and release histamine in response to hypoxia, thereby contributing to
the modulation of respiration within the rat. Here, isolated neonatal rat carotid body type
I cells were used to identify the presynaptic effects of histamine and the specific receptor
subtypes that modulate them. Although all four histamine receptor subtypes are
expressed on the type I cells, and preliminary data showed promising results, further data
proved that the activation of these receptors with histamine or selective agonists caused
no rise in intracellular calcium ([Ca2+]i) and histamine did not augment calcium entry.
Thus activation of histamine receptors on type I cells is unlikely to provide a presynaptic
positive feedback mechanism during chemotransduction and any excitatory role
attributed to the actions of histamine is likely to come from a postsynaptic effect on the
carotid sinus nerve (CSN).

Some of the data from this thesis have been accepted for publication in the journal
Respiratory Physiology and Neurobiology:

Burlon, D. C., Jordan, H. L. & Wyatt, C. N. (2009) Presynaptic regulation of isolated
neonatal rat carotid body type I cells by histamine. Resp. Physiol and Neurobiol. 168,
218-223
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CHAPTER I
INTRODUCTION

1

Why do we need to breathe? Is it an important function? What controls our
breathing?
Ever since oxygen became a freely accessible molecule on planet earth, organisms
have been using it to fuel cellular respiration. Cellular respiration, or the process of using
oxygen to produce ATP in mitochondria, is what allowed life to flourish and diversify on
earth. Because of oxygen’s role as the final electron acceptor in the electron transport
chain, single as well as multi cellular organisms have the ability to increase their energy
production. In animals, respiration is the process through which oxygen is exchanged in
the lungs for carbon dioxide, a byproduct of cellular respiration. By inhaling air into our
lungs, oxygen is delivered to the blood stream. The blood then transports oxygen to all
the cells of the body, and allows for cellular respiration to take place. This fundamental
process is pivotal for human life to exist as we know it.
For millennia man has known breathing, or respiration, was integral for survival.
What was not known however, were the structures and processes involved with the
control of our breathing. Toward the beginning of the 20th century breathing was
discovered to be influenced by specialized organs that sensed changes in the composition
of the body fluids (PO2, PCO2, or [H+]), which reflect O2 demands and CO2 production
(Heymans, 1930; Gonzalez et al., 1994). These organs were designated the peripheral
arterial chemoreceptors. Later, during the middle of the century chemoreceptor sites
within the brain also began to be identified (Leusen, 1950a, b). The work in this thesis is
concerned with neurotransmission within the peripheral arterial chemoreceptors, in
particular the carotid bodies of the rat and the role of histamine in their function.
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CHAPTER II
LITERATURE REVIEW

3

General Anatomy
The carotid bodies are the primary peripheral arterial chemoreceptors for the
control of respiration in the human body. They are sensitive to fluctuations in blood gas
as well as pH. Any change in blood gas homeostasis, such as hypoxia, hypercapnia, or
acidosis are sensed by the carotid bodies which then release neurotransmitters. This
results in the increased activity of the carotid sinus nerve (CSN) which innervates the
respiratory centers of the brain, causing increased breathing movements thereby returning
arterial PO2, PCO2 and pH to normal physiological levels.
Located at the bifurcation of the common carotid artery, in humans carotid
bodies are about the size of a grain of rice and about 1mg in weight. Although very
small, the carotid body receives the highest perfusion of blood, per gram of tissue, of any
organ in the body. Blood is delivered to the carotid bodies from multiple branches of
both the internal and external carotid arteries, and perfused through the organ by an
extensive network of capillaries. Venous drainage of the carotid bodies is completed
through both the internal and external jugular veins (Fig 1A). Innervation of this
particular organ is accomplished by two major nerves. The first is the afferent portion of
the carotid sinus nerve (CSN), a branch of cranial nerve IX or glossopharyngeal nerve,
and second is the efferent ganglioglomerular nerve from the superior cervical ganglion
(SCG). The carotid bodies particular location not only allows the organ to sample blood
that has recently passed through the lungs and heart, but allows it to relay what it senses
directly to the brain allowing respiratory changes to be made extremely rapidly.
The carotid body contains two major types of cells (Fig 1B). The type I cells are
responsible for sensing reductions in blood PO2, pH and increases in PCO2 (Buckler &
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Vaughan-Jones, 1994b, a). Once changes are detected, the type I cell begins to release
neurotransmitter. This release of neurotransmitter then evokes increased firing of the
carotid sinus nerve which ultimately innervates cells of the commissural subnucleus of
the solitary tract in the brainstem (Finley & Katz, 1992) and causes an increase in
respiration, such that blood gases are returned to physiological levels (Gonzalez et al.,
1994). Until recently it was thought that the type II cell was glial in function and acted as
‘physiological glue’ to adhere the tissue together. However, recent research has
demonstrated a more complex role for the type II cells. They have been found to have
neuroprogenitor or stem cell-like properties. Under chronic hypoxia carotid bodies
undergo hyperplasia and hypertrophy (Bee et al., 1986). It is now known that the Type II
cells are capable of division and formation of type I cells under chronic hypoxic
conditions (Pardal et al., 2007).

5

Fig 1. Structure and ultrastructure of the carotid body. A, Shows the local anatomy of the
carotid body (CC, common carotid; EC, external carotid; IC, internal carotid). B. Shows
the cellular ultrastucture of a glomoid (cluster of type I and II cells) within the carotid
body (CSN, carotid sinus nerve). Reproduced from Pardal et al (2007).
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History
The carotid bodies role as a chemosensory organ, and not a gland, was first
identified by De Castro (De Castro, 1928). Proving that fibers from the carotid sinus
nerve were sensory and not secretomotor, De Castro postulated that the carotid bodies
function was to detect changes in the chemical composition of the blood and that special
cells within the carotid body were the sensors (De Castro, 1928; Gonzalez et al., 1994).
This postulate was later confirmed by Corneille J. F. Heymans, who won the Nobel Prize
in Physiology or Medicine in 1938 with his ingenious work on canines. By performing
experiments on the isolated head of a canine (Fig 2) Heymans was able to show the
carotid body’s mediation of hyperventilation due to decreases in PO2, pH, or increases in
PCO2 (Heymans, 1930). In Fig. 2, dog A was subjected to periods of hypoxia resulting in
an increase in respiratory rate in dog B. This elegantly conducted research was pinnacle
in defining the carotid body as the primary peripheral chemoreceptor.
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Fig 2. This figure portrays the isolation of the canines head, connected with anastamoses
to the isolated trunk of another animal. Arterial blood from dog A passes into the
common carotid arteries of dog B below the level of the carotid bifurcation. Hypoxic gas
given to dog A resulted in increased breathing movements in Dog B as hypoxaemic blood
stimulated the carotid bodies of dog B.
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Chemotransduction by the carotid body

It is currently accepted that the basic mechanism of carotid body
chemotransduction is that hypoxia, or a decrease in blood oxygen, and hypercapnia, an
increase in blood CO2, inhibit K+ channels in the type I cell membranes leading to
depolarization, voltage-gated Ca2+ entry and neurotransmitter release (Iturriaga &
Alcayaga, 2004). However, type I cells release a wide variety of neurotransmitters in
response to chemostimuli and the mechanisms by which these neurotransmitters regulate
the output of the CSN are complex, exhibiting marked inter (and intra-) species
differences (Shirahata et al., 2007). Furthermore, both excitatory and inhibitory
neurotransmitters are released in a tightly regulated manner by type I cells in response to
chemostimuli with the overall response of the CSN being determined by the balance of
excitation and inhibition. Indeed, modulation of the balance of excitatory to inhibitory
neurotransmitter release has been proposed to underpin, in part, plasticity of the carotid
body during chronic hypoxic conditions (Prabhakar, 2006).
Most recently it has been demonstrated that histamine plays a role in arterial
chemoreception (Dutschmann et al., 2003), being synthesized and released in response to
hypoxia by carotid body type I cells (Koerner et al., 2004). Moreover, application of
histamine receptor 1 and 3 agonists to locally perfused carotid bodies mimicked the
chemoreceptor reflex evoked by cyanide (a potent chemostimulant (Heymans et al.,
1931)) in a decerebrate rat preparation by increasing phrenic nerve output (Lazarov et al.,
2006). However, the precise mechanism by which histamine acted at the level of the type
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I cells was not examined. An investigation of the role of histamine at the level of the type
I cell is the focus of this thesis.

Role of the Type I cell as a Chemoreceptor
It is now widely accepted that the Type I, or glomus cells, are the main
chemosensory elements within the carotid body (Verna et al., 1975) and the work by
Fricke Pietruschka on isolated Type I cells (Pietruschka & Acker, 1985) has allowed
researchers to explore further into how these cells respond to changes in the partial
pressure of oxygen.
Throughout the past couple of decades research has shown that hypoxic inhibition
of different K+ channels within the Type I cells was crucial for chemotransduction to
occur (Lopez-Barneo et al., 1988; Stea & Nurse, 1991; Wyatt & Peers, 1995). Although
the exact K+ channel is different from species to species, the general mechanism of
transduction was the same. A hypoxic event causes the closure, or inhibition, of K+
channels leading to depolarization, calcium influx through voltage-gated calcium
channels (Buckler & Vaughan-Jones, 1994b), and the eventual neurotransmitter release
(Gonzalez et al., 1994). Although this general mechanism is agreed upon, the actual
process behind how these K+ channels are inhibited continues to be a heated topic for
debate. Carotid body researchers are constantly theorizing about what the exact
mechanism is behind the hypoxic closure of these channels.
The Mitochondrial Hypothesis
Mitochondria are involved with the process of oxidative phosphorylation. When
oxygen is delivered to the cell through the blood stream, mitochondria use it to produce
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energy.

It has been shown that application of inhibitors of the mitochondrial electron

transport chain (ETC) or mitochondrial uncouplers to the carotid body increase the
afferent activity of the carotid sinus nerve (Mills & Jobsis, 1972). Therefore, inhibiting
oxidative phosphorylation will cause in increase in the amount of neurotransmitters
released from the type I cell further stimulating the carotid sinus nerve. This proposal
was supplemented by research finding that hypoxia and cyanide, an inhibitor of
mitochondrial complex IV, lead to a rise in intracellular Ca2+ in dispersed, isolated,
glomus cells (Duchen & Biscoe, 1992a, b). Further research conducted on the carotid
body has shown that hypoxia may signal via a cascading chain of events. Decreasing the
amount of oxygen a cell has available may ultimately decrease the amount of ATP that
mitochondria can produce. In most cells oxygen has to be dropped to extremely low
levels before oxidative phosphorylation is inhibited. However, this is not the case in the
carotid body and physiologically relevant levels of hypoxia will cause inhibition of Type
I cell mitochondrial oxidative phosphorylation (Duchen & Biscoe, 1992a, b). A decrease
in ATP production could trigger a mechanism that might cascade down to membrane
bound potassium channels, cause them to close, and thus depolarize the cell (Varas et al.,
2007). Another model of a mitochondrial cascade mechanism hypothesizes that by
decreasing the amount of ATP production the ATP/AMP ratio will be reduced (Wyatt &
Evans, 2007). This in turn would elicit a response from an enzyme, AMP-activated
protein kinase (AMPK), which couples to the potassium channels resulting in their
closure (see Fig. 3). Research testing this hypothesis is ongoing (Wyatt et al., 2007).
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Fig 3. Schematic showing the AMPK theory in detail. Hypoxia inhibits ATP production
by mitochondria. Adenylate kinase converts rising levels of ADP to ATP and AMP
causing AMP levels to rise. AMPK is activated and inhibits the ‘O2-sensitive’ K+
channels leading to Ca2+ influx and neurotransmitter release.
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The Membrane Hypothesis:
During a hypoxic event the type I cell depolarizes, causing an influx of Ca2+
through voltage-gated Ca2+ channels leading to release of transmitters, and afferent nerve
activation (Gonzalez et al., 1994). This was believed to happen through the direct
inhibition of K+ channels within the membranes of type I cells (Lopez-Barneo et al.,
1988).
Although there is a huge variety of K+ conductance channels within the
membrane of the Type I cell (Patel & Honore, 2001) there seems to be several classes of
more concern and importance than the others. One class is the large-conductance Ca2+activated K+ channels also known as BKCa channels (Lahiri et al., 2005). The research
conducted on these channels has shown their importance in the hypoxic response of type
I cells (Peers, 1990). The BKCa channels are thought to help control, or regulate, the
excitatory hypoxic response of type I cells by closing during hypoxic membrane
depolarization perhaps to sustain and prolong this depolarization (Lahiri et al., 2005;
Peers & Wyatt, 2007). Importantly, this occurs despite the rise in [Ca2+]i that would
activate the BKCa channels
To determine how hypoxia modulates BKCa channels the patch-clamp method
was performed on individual type I cells. Many different types of experiments were
performed on individual type I cells (Wyatt & Peers, 1995; Lewis et al., 2002) and each
showed that hypoxia alone could not directly inhibit the BKCa channels in isolated
patches. Data showed that a cytoplasmic intermediary, one that is coupled to BKCa
channels as well as chemically sensitive to drops in tissue O2, was also involved in the
excitatory hypoxic response within type I cells. However, there is also conflicting
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evidence indicating that hypoxia can inhibit BKCa in isolated patches (Riesco-Fagundo et
al., 2001). This issue remains unresolved.
A second class of oxygen-sensitive potassium channels in type I cells are
background K+ - channels, specifically those resembling TASK (TWIK-related Acid
Sensing K+) background channels. These channels show biophysical and
pharmacological similarity to both TASK-1 and TASK-3 potassium channels and are
consequently termed TASK-like background channels (Buckler et al., 2006) as their
molecular identity remains unknown. It has been shown that inhibition of these channels
by hypoxia (Buckler, 1997; Buckler et al., 2000) leads to membrane depolarization,
calcium entry (Buckler & Vaughan-Jones, 1998; Wyatt & Buckler, 2004) and eventual
neurotransmitter release (Ortega-Saenz et al., 2003). Inhibition of oxidative
phosphorylation in type I cells has also been shown to inhibit these leak conductances
(Wyatt & Buckler, 2003, 2004). Applying known metabolic inhibitors to type I cells has
been shown to mimic the response to hypoxia and in the presence of maximal
concentrations of mitochondrial inhibitors hypoxia has no effect on the TASK-like
current (Buckler et al., 2006). This shows that the effects of mitochondrial inhibition and
hypoxia on TASK-like background potassium channels are not additive, but mutually
exclusive (Wyatt & Buckler, 2004; Buckler et al., 2006), meaning, in order to generate
the effects of hypoxia, mitochondrial metabolism must be active. Whether or not
mitochondrial inhibition is directly coupled to background potassium channels is still a
hot topic for debate, but what is known is that TASK- like background K+ - channels play
a central role in initiating the response of isolated type I glomus cells to a number of
chemostimuli (Buckler et al., 2006).
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Neurotransmission within the rat carotid body
The carotid body is the key peripheral chemoreceptor for respiratory regulation
within mammals. It accomplishes this task by communicating with other type I cells, as
well as the CSN, through the use of neurotransmitters. The type I cell, for its size, has an
enormously large nucleus capable of manufacturing a seemingly endless array of
neurotransmitters, both excitatory and inhibitory. The excitatory neurotransmitters work
both pre and post-synaptically (see Fig. 4), enhancing afferent nervous transmission to
the brain and thereby increasing respiratory rate and tidal volume. Inhibitory
neurotransmitters work pre-synaptically binding to receptors present on the membrane of
the type I cells. These neurotransmitters work by decreasing the amount of excitatory
neurotransmitter released, thus providing a negative feedback mechanism. Both types of
neurotransmitters give the carotid body the ability to shape and refine its response to
perturbations in blood gases. The next part of the introduction will discuss several of the
major neurotransmitters released by type I cells and their functions relating to respiratory
regulation.
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Fig 4. Schematic showing neurotransmission within a glomoid in the carotid
body. The blue arrows show how neurotransmitters may act postsynaptically on the carotid
sinus nerve, presynaptically on the type I cell that has released the transmitter and also on
other type I cells within the glomoid.
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Excitatory Neurotransmitters: Post Synaptic
ACh and ATP – Acetylcholine and the co-release of ATP
Acetylcholine (ACh), already known to be an excitatory neurotransmitter released
from the pre-synaptic terminals of motor neurons, has been linked to play an excitatory
role in the modulation of breathing within the carotid body (Eyzaguirre & Zapata, 1968;
Gonzalez et al., 1994). ATP, a molecule used for energy, has also been shown to exhibit
abilities as an extracellular signaling molecule within the central nervous system
(Burnstock, 1997). Together, ACh and ATP are released from type I glomus cells of the
carotid body in response to changes in blood chemistry (Zhang et al., 2000). ATP then
activates purinergic receptors of the afferent fibers of the carotid sinus nerve, increasing
the rate of respiration during a hypoxic response.
Through the use of pharmacology as well as electrophysiology the effects of ACh
and ATP on postsynaptic afferent neurons have been studied. When the carotid body is
at rest, random spikes of depolarization occur in the CSN (Rong et al., 2003), but the
cause of these resting spikes of depolarization was unknown. Many neurotransmitter
antagonists have been used to quiet these spikes, but nothing has provided conclusive
results (Rong et al., 2003). To determine the mechanism behind these spikes researchers
in Colin Nurse’s group investigated the role of ACh (a carotid body neurotransmitter that
had fallen out of favor over the previous 15 years) and ATP in a novel type I cell-petrosal
ganglion co-culture experiment (Zhang et al., 2000).
Through the use of pharmacological reagents such as suramin (ATP receptor
antagonist) and mecamylamine (neuronal nicotinic Ach receptor antagonist), it was
proven that both ATP and ACh played a role in carotid bodies response to hypoxia
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(Zhang et al., 2000). In the normal control group recordings, random spiking in the
petrosal neurons would occur throughout the testing period, but when hexamethonium or
mecamylamine were applied ( nicotinic ACh receptor blockers) the spontaneous activity
was partially and reversibly repressed (Zhang et al., 2000). As for ATP, when suramin
was applied ( P2 purinoceptor blocker) a partial suppression of spontaneous activity also
occurred, even to those previously suppressed by mecamylamine (Zhang et al., 2000).
To demonstrate that the spontaneous synaptic events arose principally from co-release of
ACh and ATP from Type I cells, both blockers were tested. The result was an almost
complete abolishment of random spiking during the perfusion of suramin plus
mecamylamine. As for when the cells were perfused with a hypoxic solution, the same
results occurred. When each of the different blockers were applied there was a
significant decrease in the firing in petrosal neurons (Zhang et al., 2000).

ATP – Adenosine Tri-phosphate: Main excitatory neurotransmitter within the carotid
body
Until recently, using antagonists to stop afferent impulses delivered from the CB,
due to hypoxia, has produced conflicting results (Rong et al., 2003). To determine the
effects of ATP on purinergic P2X receptors subtypes within the carotid body (specifically
P2X2 and P2X3), plethysmography as well as electrophysiology were used. Knock-out
mice of P2X2-/-, P2X3 -/- and P2X2/P2X3Dbl-/- were created and experimented on using the
above experimental techniques.
Plethysmography, or the use of pressure to determine changes in the respiration of
an animal, was used first to determine the effects of hypoxia on knock-out mice as well
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as their wild type littermates. Each group of knock-out mice as well as their wild type
littermates were subjected to differing concentrations of O2 starting at 21% O2 and
decreasing to 7.5% O2. For the wildtype (WT) mice, a noticeable increase in respiratory
rate as well as tidal volume were observed and recorded. Of the knockouts only the P2X2
and double knockout showed significant results as compared to the WT using the student
t-test. The results showed that removal of the P2X2 receptor subtype resulted in an
attenuation of the ventilatory response to hypoxia (Rong et al., 2003).
In experiments involving electrophysiology, an intact carotid body – carotid sinus
nerve preparation (Rong et al., 2003) was used to study discharges from the afferent
fibers of the carotid sinus nerve. Pharmacological studies were performed on this model
using solutions of ATP as well as a stable analog α,βmetATP. In each of these
experiments it was shown that ATP and its stable analog caused an immediate spike in
discharge within the WT animals followed by a sustained increase for about 72-120 sec
(Rong et al., 2003). As for the knock-outs; the P2X2-/- knockout showed a rapid increase
to only ATP which lasted for only about 5 sec; P2X3-/- did not show a rapid spike in
discharge, but a sustained response after application of about 60sec; and the double
knock-out showed no rapid increase and a very mild sustained response (Rong et al.,
2003).
These results show that ATP is acting on both receptors in different ways. The
P2X3 receptors are more easily desensitized and are what create the initial burst of
afferent discharge, where P2X2 receptors stay open longer allowing for discharges to
continue over a longer period of time.

23

It is interesting to note that ATP can also activate purinergic P2Y receptors on the
type I cells (Xu et al., 2005). Activation of these receptors inhibited excitation in the type
I cells and therefore served to slow or reduce the release of neurotransmitter.
Consequently ATP can act as both an excitatory post synaptic transmitter and an
inhibitory presynaptic inhibitor.

Excitatory Neurotransmitters: Pre- synaptic
5-HT: Seratonin
Paracrine and autocrine methods of cellular communication have been shown to
help regulate the release of neurotransmitters within the carotid body (Zhang et al.,
2003). The monoamines (dopamine and serotonin) are a particular group of
neurotransmitters released from the carotid body (Gonzalez et al., 1994) that act presynaptically on type I glomus cells(Zhang et al., 2003; Carroll et al., 2005).
Serotonin, has been linked to the regulation of excitatory post-synaptic
neurotransmitter secretion, ATP and ACh, from carotid body type I glomus cells (Zhang
et al., 2003). Serotonin works in a paracrine/autocrine method binding to
5-HT receptor sites present on type I cell membranes. During periods of normoxia,
serotonin is released to create a stable resting membrane potential between adjacent cells.
Working through a G-protein coupled receptor, 5-HT2a, serotonin utilizes the second
messenger, protein kinase C, to phosphorylate K+ channels (TASK-like), closing them,
resulting in a slight depolarization of the cell (Zhang et al., 2003). It has also been shown
that during a hypoxic event, serotonin is released creating a positive feedback
mechanism. This results in a further depolarization of the cell and an enhanced
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production, and release, of both excitatory post-synaptic neurotransmitters (Zhang et al.,
2003). Therefore, serotonin helps to both regulate, as well as help exacerbate the
responses to chemostimuli perceived by the type I glomus cells.

Inhibitory Neurotransmitter: Pre-Synaptic
Dopamine
Of the two monoamines studied under carotid body physiology, dopamine has
been studied in the greatest detail (Zhang et al., 2003). This is because of the potential
involvement of dopamine in neonatal fatality or sudden infant death syndrome. At birth
the carotid body chemoreceptors have very low sensitivity to hypoxia and tend to become
more sensitive after a couple of days, a process called resetting (Carroll et al., 2005).
Although the mechanisms of resetting are unknown, research has suggested the
involvement of dopamine as a neuromodulator during this process (Carroll et al., 2005).
Similar to 5-HT, dopamine seems to be working through both paracrine and autocrine
cellular communication methods. But, unlike 5-HT, dopamine acts as an inhibitory
neurotransmitter, decreasing the amount of ATP and ACh released to the afferent fibers
of the carotid sinus nerve (Carroll et al., 2005).
Dopamine acting via D2 receptors in the carotid body of both mice and rats has
been shown to inhibit the effects of hypoxia, resulting in a decrease in the ventilatory
response (Carroll et al., 2005; Prieto-Lloret, 2007). Dopamine receptor
agonist/antagonists, as well as transgenic mice have been used to study this. In
experiments using D2 receptor agonists (quinpirole) and antagonists (sulpiride), it was
consistently shown that during periods of hypoxia, if dopamine is present, a decrease in
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intracellular calcium concentration will occur (Carroll et al., 2005). This decrease in
intracellular calcium is correlated with a decrease in neurotransmitter release from the
carotid body (Gonzalez et al., 1994).
On the contrary, in D2 knockout mice there was not a significant decrease in
ventilation as compared to their wildtype litter mates when both were subjected to
periods of increasing hypoxia (Prieto-Lloret, 2007). These observations lead to the
general conclusion that D2 receptors contribute but are not essential to CB function or
hypoxia transduction and play a role in modulating or shaping the secretory response to
hypoxia (Prieto-Lloret, 2007).

Evidence for Histamine as excitatory neurotransmitter within the Carotid Body
Because biogenic amines have been found to contribute so greatly with
respiratory modulation and control, researchers began wondering if histamine was also
involved. It was recently found that Type I cells contain histamine and have the
machinery to synthesize, store, and release it during periods of hypoxia (Koerner et al.,
2004) indicating a potentially significant role in arterial chemoreception.
In type I cells it was shown that histamine decarboxylase, the histamine
biosynthesis enzyme necessary for the formation of histamine, was present (Koerner et
al., 2004). In this same study it was also shown that the packaging materials necessary
for vesicular transport of histamine were also present. Histamine requires vesicular
monoamine transporters VMAT1 and VMAT2 in order to be released from the cell. Both
of these were found using antibodies directed against both transporters (Koerner et al.,
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2004). This would suggest that type I cells have the capability to produce as well as
release histamine if required.
Histamine is known to act via specific receptors within the mammalian body.
These receptors H1, H2, H3, and H4 all act via G-protein coupled second messenger
systems, but each elicit a different response when triggered. It has been shown that H1
and H3 are both present within rat carotid bodies (Koerner et al., 2004; Lazarov et al.,
2006), but it has yet to be shown whether these receptors are present solely on the plasma
membrane of Type I glomus cells.
By exposing the carotid body to histamine receptor 1 and 3 agonists, it was shown that
phrenic nerve activity increased in a working heart-brainstem preparation (Lazarov et al.,
2006). This would suggest that histamine excites the carotid sinus nerve, increasing
respiration during a period of hypoxia. What is not known is whether histamine is acting
in a presynaptic (on the Type I cells) or postsynaptic fashion (directly on the sinus nerve)
within the carotid body. Although not discussed in the Lazarov paper, some of the ways
histamine could be acting in an excitatory manner are defined in the next few pages.

H1 receptor
H1 Receptor activation preferentially couples to Gαq leading to stimulation of
phospholipase C (PLC) which catalyses the hydrolysis of phosphotidylinositol 4,5bisphosphate (PIP2) to form inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG)
(Hill et al., 1997). Release of IP3 may cause release of Ca2+ from intracellular stores and
DAG activates protein kinase C (PKC). This PKC activation may lead to Ca2+ dependent
cAMP accumulation, although Gβγ subunits released from Gq may also contribute to a
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rise in cAMP. More interestingly it has recently been demonstrated that Gαq may directly
inhibit TWIK related acid-sensing potassium (TASK) channels by a mechanism that is
independent of PLC-mediated PIP2 hydrolysis (Chen et al., 2006). PKC activation has
also been shown to inhibit TASK-1 (Besana et al., 2004). Thus H1 activation alone could
account for IP3-mediated release of Ca2+ from Type I cell stores and TASK channel
inhibition (by direct G protein interaction and by PKC) leading to depolarization and
voltage-gated Ca2+ entry. This potential ability to modulate TASK is interesting as
inhibition of TASK-like K+ channels has been shown to excite rat Type I cells (Buckler
et al., 2000). In addition PKC activation inhibits BKCa in rat Type I cells (Peers &
Carpenter, 1998) and this would sustain any depolarization evoked by histamine.

H2 receptor
H2 receptor activation preferentially couples to the Gs family of G proteins which
are positively coupled to adenyl cyclase, causing an increase in cAMP and thus activation
of protein kinase A (PKA). A PKA dependent pathway has recently been shown to
inhibit the TASK-like channels that contribute to setting the resting membrane potential
in rat carotid body type I cells (Xu et al., 2006; Xu et al., 2007). Thus a H2 receptor
mediated rise in cAMP could also lead to TASK channel inhibition, cell depolarization
and voltage-gated Ca2+ entry.

H3 and H4 receptors
H3 and H4 receptor activation preferentially couples to the Gi family of G
proteins which are negatively coupled to adenylate cyclase and would tend to decrease
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cAMP. This would theoretically oppose the actions of histamine at H2 receptors via
inhibition of adenylate cyclase and hence inhibition of PKA. Indeed, in general the H3
receptors are thought of as inhibitory auto receptors (Arrang et al., 1983, 1985).
However, there are limited reports suggesting that H3 receptor agonists can mobilize Ca2+
from intracellular stores (Bongers et al., 2006).

The research conducted in this thesis project utilized isolated carotid body Type I cells
and not the carotid body as a whole. This method was used to determine whether
histamine acts presynaptically on the Type I cells to further excite or inhibit the cell
during a period of hypoxia.

Summary
The carotid bodies lies at the bifurcation of the common carotid arteries, usually
directly adhered to the internal carotid artery. They are composed of two different types
of cells: The Type I glomus cell, which is chemosensory in nature, and the Type II cell,
which is more glial-like. The Type I cell has the ability to react to changes in blood
gases, as well as pH. During an adverse event, such as hypoxia or hypercapnia, the Type
I cell releases neurotransmitters which act on afferent fibers of the carotid sinus nerve.
These excitatory messages are sent to the medulla resulting in compensatory ventilatory
adjustment.
Type I cells release many different neurotransmitters when activated by changes
in blood chemistry. These neurotransmitters can either be excitatory (increasing
respiratory rate) or inhibitory (decreasing respiratory rate). Furthermore, released
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neurotransmitter may work in a presynaptic or postsynaptic fashion. The focus of the
research performed in this thesis is on the neurotransmitter histamine. Histamine
receptor agonists applied to intact rat carotid bodies have been shown to elicit increased
firing in the rat phrenic nerve. Thus histamine receptor activation in the rat carotid body
appears to be excitatory. The purpose of the work presented in this thesis was to
determine if histamine could act presynaptically on the type I cells rather than directly on
the carotid sinus nerve endings. Presynaptic Type I cell excitatory activity would amplify
the hypoxic response possibly by augmenting the release of identified postsynaptic
excitatory neurotransmitters such as ATP and Acetylcholine.
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CHAPTER III
MATERIALS AND METHODS
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All studies described in this paper were performed in accordance with protocols
approved by the Wright State University Institutional Laboratory Animal Care and Use
Committee (IACUC).These protocols are in accordance with the National Institute of
Health guide for the care and use of laboratory animals (NIH publications No. 80-23)
revised 1996.

Dissection and Dissociation of Neonatal Rat Carotid Body Type I Cells
On each day of experimentation two neonatal Sprague Dawley rats (aged 10-20
days) were placed into an induction chamber supplied with 4.5% isofluorane and oxygen
to initially anesthetize and immobilize them. When unconscious, the rat was removed
from the induction chamber and its head was carefully placed into a gas mask also
supplied with the same mixture of anesthetic gas. Once deemed completely asleep (foot
pinch withdrawal reflex was absent) the following procedure was performed: The rat
was placed on its back with both forelegs and hind legs taped down, reducing any
movement caused by the procedure. An initial incision was then made along the breast
bone to expose the underlying subcutaneous fascia. In order to expose the common
carotid artery, salivary glands as well as skeletal muscles laying lateral to the trachea
were removed with very fine forceps (Moria, Fine Science Tools, USA), being careful
not to cut or damage any of the surrounding arteries and veins.
The remaining dissection was done under low magnification using a dissection
microscope (Omâno, Japan). Once the common carotid artery became visible, any bits of
fat and fascia were removed to expose the bifurcation of the common carotid arteries
external and internal branches. Removal of both the glossopharyngeal nerve and
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occipital carotid artery revealed the small carotid body, usually adhered to the internal
carotid artery (see Fig. 1 in the Introduction). The organ was then tweezed off very
carefully, making sure to keep its integrity and placed directly into ice cold, oxygenated,
Dulbecco’s phosphate buffered saline (DPBS) without Ca2+ (to diminish neurotransmitter
release) or Mg2+ (Sigma). The rats were then humanely killed by decapitation while still
deeply anesthetized and disposed of accordingly to Lab Animal Research specifications.
The organs were then transported to the lab and cleaned of any connective tissue or
debris under increased magnification on the Omâno dissecting microscope.
Once cleaned the carotid bodies were then transferred to a digestive enzyme
solution (0.4mg ml-1 collagenase type I, 220u mg-1 (Worthington Biochemical
Corporation), 0.2 mg ml-1 trypsin type I, 10,100 BAEE u mg-1 (Sigma) in DPBS with low
CaCl2 (86 μM) and MgCl2 (350 μM)) for 20 min at 37oC in order to degrade the
connective tissue holding the organ together. The carotid bodies were then tweezed apart
and placed back into the incubator for a further 7 min digestion. The tissue was then
removed from the Petri dish and transferred to a test tube using a fire polished, silanized
(Sigmacote, Sigma), Pasteur pipette; where it was triturated and then centrifuged at 110g
for 5 min. Cells were resuspended in tissue culture medium (Ham’s F12 (Sigma)
supplemented with 10% heat inactivated fetal bovine serum (Biowest)), centrifuged again
for 5 minutes at 110g, resuspended in tissue culture medium and plated onto 22 mm2
poly-d-lysine coated coverslips for immunocytochemistry or 12 mm diameter poly-dlysine (Sigma) coated glass coverslips for imaging. Coverslips were placed in 35mm
diameter plastic Petri dishes and maintained at 37oC in a humidified, 5% CO2 / air
incubator. Cells were allowed to adhere to the coverslips for 2 hours and all cells were
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used for experimentation within 8 hours of plating. Maintaining type I cells in tissue
culture for longer periods of time results in changes to the physiological properties of the
type I cells (Tse, 1996).

Immunocytochemistry
Coverslips with attached type 1 cells were fixed by immersion in methanol at 20˚C for 20min. Cells were then permeablized by 3 x 5min washes with 0.3% triton X100 (Sigma) in phosphate buffered saline (PBS). Cells were given 3 x 5min washes with
a blocking solution (1% bovine serum albumin, 1% donkey serum, 0.3% triton X-100 in
PBS) to limit non-specific binding of the specific anti-histamine receptor antibodies.
All anti-histamine receptor 1˚ antibodies were diluted 1:100 with blocking solution,
added to the coverslips and incubated at 4˚C for 16 hours.
The specific selective anti-histamine receptor antibodies for receptors H1R, H2R
and H4R were rabbit polyclonal antibodies (Santa Cruz Biotechnology: sc20633, sc50315, sc-50313) and the selective anti-histamine antibody for receptor H3R was a goat
polyclonal antibody (Santa Cruz Biotechnology: sc33977). Cells were also stained with a
mouse anti-tyrosine hydroxyase antibody (1:2000, Sigma, T1299) to assist identification
of type I cells. Following incubation with the 1˚ antibodies, coverslips were washed 4 x
5min with blocking solution and then incubated for 1 hour, at room temperature in the
dark with 1:200 dilution of Rhodamine Red-X-conjugated affinipure donkey anti-rabbit
IgG (Jackson Immunoresearch, for H1R, H2R and H4R), Rhodamine Red-X-conjugated
affinipure donkey anti-goat IgG 2˚ antibody (Jackson Immunoresearch, for H3R) and
FITC conjugated donkey anti-mouse IgG 2o antibody (Jackson Immunoresearch, for
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tyrosine hydroxyase). Coverslips were then washed for 5 x 5min with PBS before being
inverted and attached to microscope slides with hard setting anti-fade mountant (2.4 g
Mowiol 4-88, 6 g glycerol, 6 ml H20, 12ml 0.2M Tris buffer pH 8.5, 2,5% diazobicyclooctane) containing 4’, 6-diamidino-2-2-phenylindole dihydrochloride (DAPI, 1mg ml-1)
for visualization of type I cell nuclei. For controls, 1˚ antibody was omitted during this
procedure. As a further negative control histamine receptor staining was examined in
undifferentiated NG108-15 cells that were processed in an identical manner to the carotid
body cells.
Images were acquired using a DeltaVision microscope system (Applied Precision)
on an inverted Olympus IX71 microscope with an oil immersion, x63 magnification, 1.4
n.a. objective and Coolsnap HQ CCD camera (Photometrics). Multiple z-sections (focal
depth 0.28 μm, z-step 0.25 μm) were taken through individual cells. Images were
deconvolved on-line via Softworx software (Applied Precision).

Deconvolution Microscopy
Deconvolution microscopy uses algorithms in order to redistribute out of focus
light. When taking pictures of 3D images, such as cells, not all parts of the sample are in
the same plane. This can cause the image to become blurred and out of focus. What
deconvolution microscopy does is re-route the out of focus light, using specific
algorithms in order to make all light shine from the same plane. This creates an image
that appears to be much brighter, closer and in focus (Fig 5).
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Fig 5. Image showing the effect of applying a Deconvolution algorithm to data acquired
using a conventional light microscope. The top, blurry image is from raw data and the
bottom is post-deconvolution. Image taken from http://micro.salk.edu/dv/dv.html
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Fura-2AM
Fura-2AM is a molecular probe that is used to determine intracellular calcium
concentrations through fluorescence. The acetoxymethyl ester portion of this probe
allows for the molecule to diffuse easily through the plasma membrane of the cell,
enabling researchers to avoid using more invasive techniques for loading. Once inside
the cell, the AM portion is cleaved off by the cell’s esterases and the cell-impermeant
fluorescent indicator is left behind. Upon binding Ca2+, Fura-2 exhibits an fluorescence
shift that can be observed by scanning the excitation spectrum between 300 and 400 nm,
while monitoring the emission at ~510 nm (invitrogen.com). In these experiments the
Fura-2 was excited by exposing it to both 340nm and 380nm wavelengths of light while
monitoring emissions at 510nm. Calculations made by looking at the ratios of emitted
light evoked by 340nm/380nm excitation allowed for us to determine the intracellular
concentration of calcium at specific instances in time (see below):

Thus the measured experimental ratio is directly proportional to the calcium
concentration within the cell and can be calculated by calibrating the system using a Ca
ionophore and a 0mM Ca2+ solution and a saturating Ca2+ solution (typically 5mM).
Additionally, by using two different wavelengths of light to measure concentration, we
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automatically canceled out variables such as dye bleaching and cell thickness that can
result in unwanted artifact (Figure 6).
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Fig 6: Fluorescence emission of Fura-2 at differing wavelengths
This graph shows the difference in fluorescence of Fura-2 due to excitation wavelength
and intracellular free-calcium concentration. The dye was excited at both 340 nm and 380
nm wavelengths of light. At an intracellular Ca2+ concentration of zero, the fluorescence
given off when excited with 340nm light is less than that at 380nm when viewed at
510nm. As intracellular calcium concentrations increase, the fluorescence at each
wavelength changes such that more light is emitted when excited at 340nm. Image is
taken from Molecular Probes catalogue and shows responses of Fura-2 to changes in Ca2+
in a cuvette.
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Ca2+ imaging
Cells were visualised with a Nikon TE2000U inverted microscope with a CFI
super fluor x40 oil immersion objective. Fura-2 was excited with 50 msec exposures to
340 nm and 380nm light at 0.2 - 0.5 Hz using a Lambda 10- 3 filter wheel (Sutter) and
emitted fluorescence measured at 510 nm using a CoolSNAP HQ2 CCD camera. Light
was provided by a Lambda-LS xenon arc lamp (175 watt, Sutter). Because of the
extremely high wattage of this lamp, the light was first passed through neutral density
filters of 0.7 optical densities (Chroma, USA) before reaching the cellular specimens.
Neutral density filters are capable of decreasing the intensity of light from all
wavelengths equally, therefore lowering the power of light from the source. Data
acquisition and analysis was controlled using Metafluor 7.1.2 imaging software
(Molecular Devices). 340/380 ratio images were generated on-line and time courses
showing changes in the fluorescence ratio assessed by placing regions of interest over the
type I cell images (see figure D). Only cells that responded to an 80mM K+ challenge
(KCl replaced NaCl in equimolar amounts, 80mM KCl was used to evoke maximal Ca2+
influx) with a rapid, robust and reversible increase in the fluorescence ratio were selected
for study.
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Fig 7: This figure is a screenshot from the Metafluor acquisition program. The program
gives us the ability to select specific regions of interest for data acquisition as indicated
by the dotted green and red lines. The two pale circles are type I cells excited at 340nm.
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Perfusion of Isolated Type I Cells
Isolated cells, plated on round coverslips, were placed into the perfusion chamber
(0.16ml) and washed with HEPES buffered saline solution (34-36˚C) for approximately
5-7min. Temperatures were maintained at 34-36oC by passing solutions through an inline heater (SH-27F, Warner Instruments, USA) which was feedback controlled by an
automatic temperature controller (TC-344B, Warner Instruments, USA).
After looking for cells through the Nikon TE2000U inverted microscope with a
CFI super fluor x40 oil immersion objective, a group of cells were eventually chosen and
data acquisition began using Metafluor 7.1.2 imaging software. Metafluor allows the
researcher to select a specific area of interest within the field of view of the microscope.
This program then plots the fluorescence intensity given off by the Fura-2 dye, at 510nm
and converts it to a ratio graphically. Solution changes were accomplished by switching
the solution inflow to a chamber containing the solution of choice; all solutions were
perfused by gravity. Solution exchange in the chamber was usually complete within 5
seconds.

Statistical Analysis
Data are presented as means ± standard error of the mean. Where appropriate data
were analyzed using students’ paired t tests, a value of P < 0.05 was considered
significant.
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CHAPTER IV
RESULTS
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Immunocytochemistry
We used anti-histamine receptor antibodies to determine the subtypes of
histamine receptors expressed in isolated neonatal rat type I cells. All cells tested
demonstrated strong staining for H1R, H2R, H3R and H4R and cytoplasmic staining for
tyrosine hydroxylase (Figs. 8 and 9). Each receptor was stained on three different days
with different cell isolates similar profiles were seen each time. Results are described
qualitatively rather than quantitatively.

Staining Profiles for Histamine Receptors
H1 Receptor: Staining indicated that receptors were targeted to the cell membrane and
also the cytoplasm (Fig. 8, H1). Little staining was seen in the nuclear space (see Fig 9,
H1 where DAPI staining has been omitted).

H2 Receptor: Staining was present at the membrane and throughout the cytoplasm. The
strongest staining was cytoplasmic (Figs. 8 & 9, H2) and some low level nuclear staining
could also be observed (Fig. 9, H2).

H3 Receptor: H3 receptors were very clearly targeted to the type I cell plasma
membranes (Figs. 8 & 9, H3) with little or no cytoplasmic staining. Nuclear staining
could be observed in some cells (Fig. 9, H3) but this was variable and not every type I
cell showed this pattern of distribution (see Fig. 8, H3 for an example where nuclear
staining was not observed).
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H4 Receptor: H4 receptors were also strongly targeted to the type I cell plasma
membrane (Figs.8 & 9, H4). The H4 receptors also showed some cytoplasmic
distribution but little or no nuclear staining was observed.
No staining was observed in control type I cells where 1˚ antibodies were omitted
see Figs. 8 & 9, Con H1,2,3,4). Additionally the histamine receptor staining in
undifferentiated NG108-15 cells was diffuse and of similar intensity to that seen when
the 1˚ antibodies were omitted (data not shown) indicating that 1˚ antibodies were not
non-specifically binding to cell membranes. Undifferentiated NG108-15 cells do not
express histamine receptors (no citations found) and so any staining seen in these cells
would be as a result of non-specific antibody interactions.
These results suggest, that in the neonatal rat carotid body, histamine released
from type I cells may bind presynaptically to 4 histamine receptor subtypes. All four
Histamine receptor subtypes showed staining at the plasma membranes. H3 and H4
receptors showed the clearest membrane targeting followed by H1 and H2 receptors.
However, variation did occur and an attempt to quantify the staining data could be made
to try and determine which receptor predominates at the membrane. This work was
outside the scope of this thesis but is commented on in the discussion.
Activation of all 4 histamine receptors could engage a multitude of G-protein
coupled second messenger systems (Gi/o, Gq, and Gs) which could excite or indeed inhibit
type I cells. Furthermore, all 4 histamine receptors may signal via modulation of
intracellular Ca2+ [Ca2+]i , see introduction. Therefore we used Fura-2-fluorescent
imaging to assess the effect of histamine (10μM, 100μM and 300μM) on [Ca2+]i in
isolated neonatal rat type I cells.
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Fig 8. Histamine receptor subtype immunofluorescence in isolated carotid body type I
cells. Images show example z-sections taken through the center of type I cells. The
fluorescent red color marks places where H1, H2, H3 and H4 receptors were found using
immunocytochemistry. The fluorescent blue color represents the nucleus of Type I cells.
Control images show absence of 2˚ antibody staining when 1˚ antibodies were absent.
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Fig 9. Type I cells are known to be dopaminergic, therefore containing the enzyme
tyrosine hydroxylase (develops the precursor to dopamine, DOPA). The fluorescent
green color represents the presence of tyrosine hydroxylase. This stain was used to assist
in the identification of type I cells. Red staining represents histamine receptor
localization. Scale bar is 10µm.

51

H1

H3

H2

H4

Con TH

Rhod-red

DAPI

FITC

52

Effect of Histamine on [Ca2+]i
Histamine (100μM) was bath applied to isolated neonatal rat type I cells.
Histamine’s activity at all 4 receptor sybtypes is similar with pD2 values for histamine at
H1R, 6.8; H2R, 6.0; H3R, 7.4; and H4R, 6.8. pD2 values represent the –log10 of the
dissociation constant for an agonist at its receptor. The pD2 values therefore represent a
measure of affinity of an agonist for its receptor. Here there is little difference between
the histamine receptors affinity for histamine. Thus this concentration of histamine
should not preferentially activate any one receptor and should evoke a robust response
from all receptors present.
To make sure the cells we tested were living and viable, only cells that responded
with rapid, robust and fully reversible responses to 80mM K+ were selected for
experimentation. 100μM histamine was the first concentration applied to the type I cells
listed above. 100μM histamine was chosen based on the receptors pD2 values. At this
concentration based on the pD2 values for this drug, all histamine receptor subtypes
should be activated strongly. Of the 34 cells tested, histamine (100μM, 90 seconds)
evoked a sustained rise in the Fura-2-fluorescence ration in 44.1% of cells or n=15 ( Fig.
10A, 0.44 ± 0.08 ratio units, P < 0.0001) and the sustained response was usually preceded
by rapid spiking activity. Rarely, brief single spike responses with no sustained
component to histamine at this concentration were observed (11.7 % of cells, Fig. 10B)
and the remainder of cells showed little or no change in Ca2+ in response to a histamine
challenge ( 37.9% of cells, Fig. 10C).
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Fig 10. Various effects of 100μM histamine on type I cell Fura-2 fluorescence ratio. K
indicates the time interval 80mM K+ solution was perfused over the cells; H is for
histamine; all scale bars are 3 minutes. On each graph, histamine was perfused for 90 sec
and the results were recorded using the program MetaFluor. A) Graph showing the
sustained response when exposed to 100μM histamine. B) Example of transient response
with 100μM histamine. C) Example of non responder with 100μM histamine. D) Bar
graph showing the percentage of responders and non responders in 34 cells.
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Dependence of Histamine evoked rise in [Ca2+]i on extracellular Ca2+
As mentioned in the introduction histamine could evoke a rise in [Ca2+]i by many
different signaling pathways. H1 and H2 receptor mediated pathways could induce
depolarization and voltage-gated calcium entry as well as mediating Ca2+ release from
intracellular stores. There are also limited reports that H3 receptors can couple to release
of intracellular Ca2+. Consequently, as the immunocytochemistry data indicated that all 4
histamine receptors are present on type I cells the source of the rise in [Ca2+]i was
examined.
To determine if histamine was evoking Ca2+ influx from the extracellular solution
the CaCl2 was removed from the solution and 1mM ethylene glycol-bis(2-aminoethyl)N,N,N’,N’-tetra acetic acid (EGTA) was added to chelate any free Ca2+ in the
extracellular solution. Histamine (100µM) was added to cells for 90 seconds and if a
sustained rise in [Ca2+]i was observed then the calcium free extracellular solution was
perfused over the cells when the peak of the response had been reached.
Under these conditions removal of extracellular Ca2+ partially reversed the
sustained rise in [Ca2+]i to histamine (100 μM) by 50.9

8.6% (n = 6, P < 0.01, Fig. 11A

and B). Thus the sustained rise in [Ca2+]i is caused by a combination of both Ca2+ influx
and Ca2+ release from intracellular stores.
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Fig 11.

Effects of 100µM histamine on type I cell Fura-2 Fluorescence ratios. A)

Example recording showing a sustained response to 100µM histamine followed by the
removal of extracellular calcium. This was performed in order to tell whether Ca2+ was
coming from extracellular on intracellular stores. B) The blue bar represents the amount
Ca2+ dropped with 0mM Ca2+ as compared to the normal extracellular calcium
concentration (red).

57

H

0Ca

(F 340/F380)

A 1.8 K

3 Min

B

0

(F340/F380)

0.9

0

p<0.01

2.5m M

0m M

58

Effect of Histamine agonists on [Ca2+]i
In order to identify which histamine receptors were contributing to the rise in the
Fura-2 ratios observed with histamine we investigated the effects of 4 selective histamine
receptor agonists on Fura-2 fluorescence in isolated type I cells.
Bath application of the H1 receptor agonist histamine trifluoromethyl toluidide (
HTMT dimaleate, 30 M, 90 seconds) failed to induce a sustained rise in the Fura-2
fluorescence ratio in all 17 cells tested. 2 cells showed a brief single Ca2+ spike however
the majority of cells 98.2%) showed no response to HTMT dimaleate (Fig. 12). The
selective H2 receptor agonist amthamine hydrobromide (30 M, 90 seconds) initiated
spiking activity in the Fura-2 fluorescence ratio in isolated type I cells with 66.6% (10
cells from 15 tested) responding with a repeated spiking increase in the Fura-2
fluorescence ratio (Fig. 13A). This spiking activity developed into a sustained response
in 40% of responding cells (Fig. 13B).
The H3 receptor agonist (R)-(-)- -methylhistamine hydrobromide (30nM)
consistently evoked sustained rises in the type I cell Fura-2 fluorescence ratio of 0.46
0.06 ratio units (P <0.002, n = 5, Fig. 14)
The H4 receptor agonist 4-methylhistamine dihydrochloride (1 M) also evoked
sustained rises in Fura-2 fluorescence ratio of 0.65
15).
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0.09 ratio units (P < 0.006, n=4, Fig

Fig 12. Pharmacological stimulation of the H1 histamine receptor subtype using the H1
selective histamine agonist, HTMT dimaleate, at a concentration of 30μM. Bath
application of the agonist failed to raise intracellular Ca2+ concentrations in 17 different
type I cells.
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Fig 13. Pharmacological stimulation of the H2 histamine receptor subtype using the H2
selective receptor agonist, Amthamine Hydrobromide, at a concentration of 30μM. Bath
application of the H2 receptor subtype agonist elicited two different responses in the
Fura-2 fluorescence ratio. Graphs showing the A) transient response in 10/15 cells and B)
the transient to sustained response in 4/10 that responded. 5 of the cells did not respond
at all.
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Fig 14. Pharmacological stimulation of the H3 histamine receptor subtype using the H3
selective receptor agonist, (R) - (-) – α – methylhistamine hydrobromide , at a
concentration of 30nM. Bath application of the H3 receptor subtype agonist evoked
sustained responses in 5 cells with a Fura-2 fluorescence ratio of 0.46 ± 0.06 ratio units.

64

K H3

(F340/F380)

1.2

0

3 Min

65

Fig 15. Pharmacological stimulation of the H4 histamine receptor subtype using the H4
selective receptor agonist, 4 – methylhistamine dihydrochloride, at a concentration of
1μM. Bath application of the H4 receptor subtype agonist evoked sustained rises in the
Fura-2 fluorescence ratio of 0.65 ± 0.09 ratio units. ( P< 0.006, n =4 ).
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Concentration Dependence of Histamine Response
After observing the Type I cells responses to the histamine (100µM), we began to
wonder if the type I cell response was dose dependent. Approximately 40% of type I cells
had not responded to histamine (100 µM). It appeared that type I cells did respond in a
dose dependent manner to histamine with 100% of cells responding to histamine
(300μM, 90 seconds) with a reversible sustained rise in the Fura-2-fluorescence ratio
(Fig. 16A, 0.69 ± 0.05 ratio units, P < 0,00001, n = 13). In contrast, of 34 cells tested,
histamine (100μM, 90 seconds) only evoked a sustained rise in the Fura-2 fluorescence
ratio in 44.1% of cells (Fig. 16B, 0.44 ± 0.08 ratio uints, P < 0.0001, n = 15) and the
sustained response was usually preceded by rapid spiking activity.
However, when the concentration of histamine was reduced it was noticed that at
a concentration of 10μM and even 0μM histamine a large sustained response continued to
occur (Fig. 17A, 0.53 ± 0.04 ratio units, n = 5 and Fig. 17B, 0.68 ± 0.09 ratio units, n = 3
respectively). Indeed the response to 10 µM was greater than that observed with 100
µM. The fact that similar responses were seen when control extracellular solution with no
added histamine was perfused onto the cells suggested that the data being observed were
artifactual.
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Fig 16. Graphs representing dose response experiments performed on individual type I
glomus cells with no neutral density filter. A) Bath application of 300μM histamine
evoked a sustained rise in the Fura-2 fluorescence ratio of 0.69 ± 0.05 ratio units ( p <
0.00001, n = 13) as compared to the application of B) 100μM histamine which only
accounted for a rise of 0.44 ± 0.08 ratio units. (p < 0.0001, n = 15 ).
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Fig 17. Graphs representing dose response experiments performed on individual type I
glomus cells with no neutral density filter. A) Bath application of 10μM histamine
evoked a sustained rise in the Fura-2 fluorescence ratio of 0.53 ± 0.04 ratio units ( n = 13)
as compared to the application of B) 0μM histamine which accounted for a rise of 0.68 ±
0.09 ratio units. (n = 3).
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Effects of Histamine and Agonists on [Ca2+]i with the addition of a 0.7
Neutral Density Filter

It was decided to incorporate the use of a neutral density filter in order to dampen
the suspected harmful effects of ultra violet light in the Ca2+ imaging system (see
discussion). In order to determine what filter to use a range of filters from 0.6 – 0.9o.d
(Chroma) were tested. With each filter only saline was bath applied and the effects were
recorded from Fura-2 loaded cells. At the lowest range of 0.6, allowing only 25% light
transmission, there continued to be noticeable spiking during the saline application
similar to the results seen previously with H2 receptor agonist (Figs. 18A and B). A
higher grade neutral density filter of 0.9 was then applied. This resulted in the
eradication of random spiking. It was also found that a 0.7 (12.5% light transmission)
neutral density filter eradicated random spiking of type I cells (Fig 18C).
After discovering that a neutral density filter was capable of decreasing the
occurrence of random spiking within type I cells, new experiments were conducted
testing its effects on the suspected artifact found during the initial rounds of
experimentation. First a very high concentration of 300μM histamine was bath applied to
the type I cells for a period of 90 seconds each after the initial 80mM K+ stimulus. This
resulted in 0 out of 20 cells responding to histamine at this concentration (Fig 19).
Each histamine receptor agonist was then used again to determine their effects on type I
cells together with the 0.7 neutral density filter. The first agonist used was the H1
receptor subtype agonist, HTMT dimaleate, at a concentration of 30μM. The agonist
was bath applied for 90 seconds after the intial potassium stimulus. Out of 17 cells tested
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0 responded to the application of the agonist (Fig. 20). Secondly, the H2 receptor
subtype agonist, Amthamine Hydrobromide, was used at a concentration of 30μM.
Again, out of the 6 cells tested 0 responded to the drug at this concentration (Fig. 21).
Thirdly, the H3 receptor subtype agonist, (R) - (-) – α – methylhistamine hydrobromide,
was used again at a concentration of 30nM. Similar results were found, out of the 6 cells
tested 0 responded to the drug at this concentration (Fig. 22).
With the incoroporation of the neutral density filter, no cells responded with a
sustained or transient response to histamine or the specific agonists. These data
demonstrate that histamine as well as selective histamine receptor agonists do not have an
effect on intracellular calcium in carotid body type I glomus cells.
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Fig 18. Neutral density filter selection. A) and B) 0.6 ND filter was used allowing only
a 25% transmission of light; Cells were only subjected to HEPES buffered saline
solution; noticeable random spiking still occurred at this density. C) 0.7 ND filter
(12.5% transmission) added, and resulted in the eradication of random spiking within the
isolated cells.
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Fig 19. Effects of 300μM histamine on type I cells with the incorporation of the 0.7 ND
filter. Out of 20 different cells tested, not a single one responded to the bath application
of 300μM Histamine. 80mM K+ was initially perfused over the cells to determine
whether or not the cells were viable to experimentation.
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Fig 20. Pharmacological stimulation of Type I cells with the H1 receptor subtype
agonist, at a concentration of 30µM, with the incorporation of the 0.7 ND filter. Out of
17 cells tested, 0 showed a sustained response. 80mM K+ was applied both before and
after application of the agonist.
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Fig 21. Pharmacological stimulation of Type I cells with the H2 receptor subtype
agonist, at a concentration of 30µΜ, with the incorporation of the 0.7 ND filter. Out of 6
cells tested, 0 showed a sustained response. 80mM K+ was applied both before and after
application of the agonist.
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Fig 22. Pharmacological stimulation of Type I cells with the H3 receptor subtype
agonist, at a concentration of 30nM, with the incorporation of the 0.7 ND filter. Out of 6
cells tested, 0 showed a sustained response. 80mM K+ was applied both before and after
application of the agonist.
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CHAPTER V
DISCUSSION
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Results Summary
Through the use of immunocytochemistry it was observed that all 4 histamine
receptors were present on or around the plasma membrane of carotid body Type I cells.
During the initial rounds of experimentation it was shown that histamine could play a role
in the dose dependent excitation of Type I cells, but additional experimentation proved
that the data gathered were a result of artifact instead. Following these findings further
experiments were performed on isolated Type I cells and the data collected showed no
excitatory effects of histamine on intracellular calcium in Type I cells isolated from
neonatal rat carotid body.

Despite all the pathways described in the introduction histamine does not appear to
couple to Ca2+ signaling in type I cells. Why might this be?

Are the Histamine Receptors Genuinely at the Membrane of Type I cells?
The limited staining performed in this study showed positive results for all 4
histamine receptor subtypes, but attempting to assess which receptors were most strongly
targeted to the plasma membrane was not carried out. This procedure could have been
done utilizing a specific program within the deltavision microscope. This program would
have enabled the calculation of the percentage staining within a micron of the cell
perimeter, and would have indicated which receptor subtype was the most strongly
membrane targeted. However, comparing the staining intensity between antibodies is
problematic because of different antibodies’ affinities for their receptors. Although one
antibody shows a more intense staining pattern around the membrane does not
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necessarily mean it is more present. The higher signal could just be due to the stronger
binding potential of that antibody to its specific receptor subtype.
Although staining for these receptors should be most visible at or around the
plasma membrane, extensive staining within the cytoplasm as well as the nucleus was
observed. One reason could be that the antibodies used for this particular set of
experiments were of poorer quality than what was anticipated. An experiment using
histamine antibodies from a different source and comparing staining patterns could rule
out this finding. This notwithstanding it has been observed that the staining of ryanodine
receptors, whose expression is usually restricted to the endoplasmic reticulum, were
present in the nuclei of cells (Kinnear, 2008). Therefore the antibodies could be binding
to premature histamine receptor subtypes before they are transported to the plasma
membrane from the nucleus.
From the data collected (Fig. 8 & 9) the receptors showing strongest membrane
staining appear to be the H3 and H4 histamine receptor subtypes. However, these
subtypes are usually thought to be inhibitory when activated, not excitatory (Arrang et
al., 1983, 1985). However it should be noted that when Lazarov et al injected H3 agonist
into the carotid body they observed excitation.
To absolutely confirm the expression of histamine receptor subtypes at the
membrane of Type I cells antibodies that bind to extracellular epitopes of the receptors
should be applied to non-permeablised living type I cells. The cells should then be
washed and fixed. Any membrane staining observed should be due to the presence of
histamine receptors in the type I cell plasma membrane.
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Age and species differences
Age could have been an important factor in why different results were gathered.
In Lazarov’s experiments where histaminergic agonists stimulated respiration adult rats
were used instead of the young rats used in ours (10-20 days). However, previous
research has shown no significant difference between 10-20 day old animals and adults in
the hypoxic response of the carotid body (Kholwadwala & Donnelly, 1992). Also, it has
been shown that isolated Type I cells isolated from rats of the same age range as that used
in our study have a mature hypoxic response (Pepper et al., 1995), so age is unlikely to be
a major influence on whether or not histamine is excitatory.
Interestingly it has been indirectly shown that histamine is excitatory in carotid
body Type I cells in cats. Histamine does not appear to stimulate the post synaptic
petrosal ganglion (Del Rio et al., 2008) but does excite the CSN when injected into the
carotid body. Unfortunately this experiment was performed using another species to the
rat and there are numerous species differences between cat and rat carotid body. The
parallel experiment using rats has not been performed. Furthermore the recordings in the
cat were made on the cell bodies of the petrosal ganglion and not their dendrites within
the carotid body. It is possible that receptors expressed at the cell bodies of petrosal
ganglion neurons are radically different from those expressed at the postsynaptic
terminals that type I cells communicate with. No attempt to characterize this has been
made.
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Were Cells Damaged by Enzyme Dissociation Process?
During the dissociation process harsh enzymes, such as trypsin, were used to
break down the surrounding tissue in order to help free and isolate the carotid body Type
I cells. During this process it is possible that the integrity of the proteins that compose
histamine receptors were compromised resulting in the lack of response when exposed to
histamine. If this was the case, then G-protein coupled receptor damage would be the
cause for the lack of response to histamine application.
Experiments were performed to determine the integrity of G-protein coupled
receptors using the muscarinic agonist acetyl-β-methylcholine (100µM). Previous work
has shown that muscarinic agonists induce rises in [Ca2+]i in neonatal rat type I cells
(Dasso et al., 1997). This agonist was bath applied to isolated Type I cells and the results
were recorded using the MetaFluor program. The resulting data from this experiment
showed that when the muscarinic agonist was bath applied the cells responded with
spking rises in [Ca2+]i (n = 6). Thus it appears that G-protein coupled receptors, or at least
muscarinic receptors, were not enzymatically damaged during the dissociation process
used during this thesis work (Fig. 23).

Does Histamine augment Calcium entry?
Another possibility for the lack of response to histamine during bath application is
that it works in an additive fashion, effective only when the cell has already been
depolarized. It could be that histamine is amplifying Ca2+ influx by regulating voltage
gated calcium entry (see Introduction). If histamine did work in an additive fashion, then
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applying it during a period of depolarization should further increase the effects causing a
greater spike in the Fura-2-fluorescence ratio graph.
An experiment was performed to determine whether or not histamine further
excited the cell during a depolarizing event. Type I cells were isolated as before and
subjected to high levels of potassium. During these events, histamine (300 µM) was also
applied and the results were recorded using the MetaFluor program. The resulting data
showed that at no point during the application of both the high molarity potassium and
histamine did the ratios increase, or even change (Fig. 24, n = 6). This is evidence for
that histamine does not further amplify Ca2+ influx by regulating voltage gated calcium
entry.
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Fig 23. Graph demonstrating functional g-protein coupled muscarinic receptors in the
plasma membrane of Type I cells. M represents the amount of time the muscarinic
agonist was bath applied to the Type I cell.
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Fig 24. Graph determining whether or not histamine amplifies Ca2+ influx by regulating
voltage gated calcium channels. 80mM K+ solution was applied three times. After the
first application of potassium, 300µM histamine was bath applied. During the middle of
the histamine application high potassium was placed back on to see if there were any
changes in the fura-2 fluorescence ratio. The graph clearly shows no significant changes
to the spikes during or after the application of histamine.
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What Caused the Artifact?
Ultra Violet Light and Reactive Oxygen Species (ROS)
The artifact presented itself when our Type I cells were exposed to bright
Ultraviolet light. Dimming this light by the use of neutral density filters enabled the
artifact to be titrated out. The wavelengths of excitatory light used in all the preceding
experiments were 340nm and 380nm of light. This puts them into the Ultraviolet A, or
long wave UV light category. Although these particular wavelengths are not as harmful
as shorter wavelength UVB light, when cells are exposed to them for extended periods of
time cell damage can eventually occur (Orit Bossi, 2008).
Reactive oxygen species (ROS) are molecules known to participate in cellular
damage, oncogenesis, mutagenesis and biological aging (Peter Koncz, 2006). The effects
of ROS are determined by the rate of its formation and elimination (Peter Koncz, 2006).
The major site of ROS production is within the mitochondria. It has been shown that UV
light can induce the formation of ROS (Peter Koncz, 2006). This formation of ROS
could explain the gradual, slow increase in intracellular Ca2+ as the experiment
progressed, but could not explain why the cell was able to remove the excess calcium
over a period of time and return to its original baseline Fura-2 Fluorescence ratio.
It is also possible that the overexposure to UV light was damaging the cellular
plasma membrane, compromising its integrity and thereby allowing calcium to flow into
the cell (Maglio, 2005).
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CHAPTER VI
FUTURE DIRECTIONS
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The data collected during this thesis prove there are still many questions left
unanswered in determining whether or not histamine plays a role in the modulation of
respiration by the carotid body. The direction that the lab is going after this thesis is
looking at whether histamine acts to potentiate hypoxia within the carotid body,
meaning, that during a hypoxic event, histamine will cause an even greater influx of
calcium within the type I cell. In this hypothesis, histamine is not acting as a modulator as
previously thought but as a potentiator, increasing the release of excitatory
neurotransmitters. Furthermore, it would be interesting to investigate whether histamine
can potentiate the effects of other excitatory presynaptic neurotransmitters. During a
hypoxic episode multiple neurotransmitters will be released. It is conceivable that
histamine alone is not excitatory but in combination with acetylcholine or serotonin
causes enhanced calcium signaling. The muscarinic receptor subtypes in rat type I cells
have not been characterized and histamine could, in theory, synergise with the G-protein
coupled signaling cascades activated by these receptors.
It would also be interesting to see if histamine is acting in a negative fashion,
acting as a sort of double negative. It could be possible that histamine is inhibiting an
inhibitory neurotransmitter, thereby increasing the release of excitatory neurotransmitters
to the post synaptic carotid sinus nerve. An experiment that could be run to test this is
applying histamine with a known type I cell inhibitor, such as dopamine, and seeing
whether or not there is any excitation or attenuated inhibition within the type I cell.
Finally, if histamine does not seem to have any excitatory mechanisms
presynaptically its actions postsynaptically should be investigated. This could be done
using an intact carotid body, carotid sinus nerve preparation. Selective potent antagonists
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of the various histamine receptors should be able to determine if any of the postsynaptic
CSN activity observed during hypoxia is attributable to histaminergic neurotransmission.
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